MetLife Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-25,529
| Closed | -$80.4K | – | 2359 |
|
|
2020
Q3 | $80.4K | Sell |
25,529
-27,247
| -52% | -$85.8K | ﹤0.01% | 2248 |
|
|
2020
Q2 | $154K | Hold |
52,776
| – | – | ﹤0.01% | 2050 |
|
|
2020
Q1 | $149K | Sell |
52,776
-23,225
| -31% | -$65.5K | ﹤0.01% | 1858 |
|
|
2019
Q4 | $247K | Hold |
76,001
| – | – | ﹤0.01% | 1862 |
|
|
2019
Q3 | $164K | Hold |
76,001
| – | – | ﹤0.01% | 2054 |
|
|
2019
Q2 | $239K | Hold |
76,001
| – | – | ﹤0.01% | 1924 |
|
|
2019
Q1 | $283K | Hold |
76,001
| – | – | ﹤0.01% | 1783 |
|
|
2018
Q4 | $220K | Hold |
76,001
| – | – | ﹤0.01% | 1856 |
|
|
2018
Q3 | $200K | Hold |
76,001
| – | – | ﹤0.01% | 2082 |
|
|
2018
Q2 | $178K | Buy |
76,001
+34,078
| +81% | +$79.8K | ﹤0.01% | 1975 |
|
|
2018
Q1 | $123K | Sell |
41,923
-35,608
| -46% | -$104K | ﹤0.01% | 2121 |
|
|
2017
Q4 | $212K | Buy |
+77,531
| New | +$212K | ﹤0.01% | 1903 |
|